Author

Karina Jin Yoon

University of Alabama at BirminghamORCID 0000-0002-0830-571XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:imaging· 1

Frequent Co-Authors

Bassel F. El‐RayesiD· 2 shared Dhana Sekhar Reddy BandiiD· 2 shared Ganji Purnachandra NagarajuiD· 2 shared Jeremy B. FooteiD· 2 shared Mehmet AkceiD· 2 shared Sejong BaeiD· 2 shared Sujith SarveshiD· 2 shared Adam B. KeetoniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Bassel F. El‐RayesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ProAgio, a Novel Integrin αvβ3 Targeted Cytotoxin, Suppresses Tumor Growth and Reprograms the PDAC Microenvironment

Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Ganji Purnachandra Nagaraju, Harrison Kim, Jeremy B. Foote, Sejong Bae, Karina Jin Yoon, Midhun Malla, Ashiq Masood, Mehmet Akce, Zhi-Ren Liu, Bassel F. El‐Rayes

ProAgio, an integrin αvβ3-targeted cytotoxin, enhances GPH therapy in PDAC by modulating the tumor microenvironment and improving immune responses.

bioRxiv · Jan 16, 2026 · PreprintCancer Biology

ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma

Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff, Yu-Hua Dean Fang, Adam B. Keeton, Xi Chen, Jacob Valiyaveettil, Kristy L. Berry, Sejong Bae, Mehmet Akce, Greg S. Gorman, Karina Jin Yoon, , Bassel F. El‐Rayes

ADT-1004, a pan-RAS inhibitor, shows strong antitumor activity in pancreatic ductal adenocarcinoma models with high selectivity and tolerable dosing.

Molecular Cancer · Mar 13, 2025Peer-reviewedCancer Biology